Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Adler, 1979, Fatty liver hepatitis and cirrhosis in obese patients, Am J Med, 67, 811, 10.1016/0002-9343(79)90740-X

Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo Clinic experience with an hitherto unnamed disease, Mayo Clin Proc, 55, 434

Angulo, 2002, Nonalcoholic fatty liver disease, N Engl J Med, 16, 1221, 10.1056/NEJMra011775

Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573

Farrell, 2003, Okuda Lecture. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region, J Gastroenterol Hepatol, 18, 124, 10.1046/j.1440-1746.2003.02989.x

Neuschwander-Tetri, 2003, Nonalcoholic steatohepatitis: summary of an AASLD single topic conference, Hepatology, 37, 1202, 10.1053/jhep.2003.50193

Chitturi, 2001, Etiopathogenesis of nonalcoholic steatohepatitis, Semin Liv Dis, 21, 27, 10.1055/s-2001-12927

Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8

Brunt, 1999, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol, 94, 2467, 10.1111/j.1572-0241.1999.01377.x

Kleiner, 2005, Design and validation of a histological scoring system for non-alcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701

Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084

Mendler, 2005, Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease, Liver Int, 25, 294, 10.1111/j.1478-3231.2005.01052.x

Gramlich, 2004, Pathologic features associated with fibrosis in nonalcoholic fatty liver disease, Hum Pathol, 35, 196, 10.1016/j.humpath.2003.09.018

George, 1998, Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis, Gastroenterology, 114, 311, 10.1016/S0016-5085(98)70482-2

Bonkovsky, 1999, Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis, J Hepatol, 31, 421, 10.1016/S0168-8278(99)80032-4

Norton, 1987, Alcohol consumption and the risk of alcohol related cirrhosis in women, Br Med J (Clin Res Ed), 295, 80, 10.1136/bmj.295.6590.80

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis, 2002, 2002June 10-12, 2002., Hepatology, 36, S3

Hayashi, 2004, Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related, Am J Gastroenterol, 99, 76, 10.1046/j.1572-0241.2003.04013.x

Musso, 2003, Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis, Hepatology, 37, 909, 10.1053/jhep.2003.50132

Solga, 2004, Dietary composition and nonalcoholic fatty liver disease, Dig Dis Sci, 49, 1578, 10.1023/B:DDAS.0000043367.69470.b7

Nomura, 1988, Prevalence of fatty liver in a general population of Okinawa, Japan, Jpn J Med, 27, 142, 10.2169/internalmedicine1962.27.142

Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004

Hasan, 2002, Prevalence and risk factors for nonalcoholic fatty liver in Indonesia [Abstract], J Gastroenterol Hepatol, 17, S154

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Jimba, 2005, Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults, Diabet Med, 22, 1141, 10.1111/j.1464-5491.2005.01582.x

Hilden, 1977, Liver histology in a‘normal'population: examination of 503 consecutive fatal traffic casualities, Scand J Gastroenterol, 12, 593, 10.3109/00365527709181339

Ground, 1982, Liver biopsy in review, Aviat Space Environ Med, 53, 14

Marcos, 2000, Selection and outcome of living donors for adult to adult right lobe transplantation, Transplantation, 69, 2410, 10.1097/00007890-200006150-00034

Hwang, 2004, The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation, Liver Transpl, 10, 721, 10.1002/lt.20172

Patt, 2003, Prevalence of transaminase abnormalities in asymptomatic healthy subjects, Dig Dis Sci, 48, 797, 10.1023/A:1022809430756

Wanless, 1990, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors, Hepatology, 12, 1106, 10.1002/hep.1840120505

Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540

Marceau, 1999, Liver pathology and the metabolic syndrome X in severe obesity, J Clin Endocrinol Metab, 84, 1513, 10.1210/jcem.84.5.5661

DelGaudio, 2001, Liver damage in obese persons, Obes Surg, 11, 254

Luyckx, 1998, Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty, Int J Obes, 22, 222, 10.1038/sj.ijo.0800571

Silverman, 1995, Regression of hepatic steatosis in morbidly obese persons after gastric bypass, Am J Clin Pathol, 104, 23, 10.1093/ajcp/104.1.23

Kral, 2004, Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis, Surgery, 135, 48, 10.1016/j.surg.2003.10.003

Roberts, 2002, Steatohepatitis in children, Best Pract Res Clin Gastroenterol, 16, 749, 10.1053/bega.2002.0331

Manton, 2000, Non-alcoholic steatohepatitis in children and adolescents, Med J Aust, 173, 476, 10.5694/j.1326-5377.2000.tb139299.x

Bacon, 1994, Nonalcoholic steatohepatitis: an expanded clinical entity, Gastroenterology, 107, 1103, 10.1016/0016-5085(94)90235-6

Chitturi, 2002, NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome, Hepatology, 35, 373, 10.1053/jhep.2002.30692

Pagano, 2002, Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association, Hepatology, 35, 367, 10.1053/jhep.2002.30690

Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161

Angelico, 2003, Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases, J Gastroenterol Hepatol, 18, 1115, 10.1046/j.1440-1746.2003.02958.x

Kral, 1993, Body fat topography as an independent predictor of fatty liver, Metabolism, 42, 548, 10.1016/0026-0495(93)90210-F

Omagari, 2002, Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics, J Gastroenterol Hepatol, 17, 1089, 10.1046/j.1440-1746.2002.02846.x

Adams, 2004, Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction, Hepatology, 39, 909, 10.1002/hep.20140

Hashimoto, 2004, Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis, Alcohol Clin Exp Res, 28, 8, 10.1111/j.1530-0277.2004.tb03237.x

Adams, 2005, The natural history of nonalcoholic fatty liver disease: a populationbased cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014

Poynard, 2000, Fibrosis in patients with chronic hepatitis C: detection and significance, Semin Liver Dis, 20, 47, 10.1055/s-2000-9258

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889

Thomas, 2005, Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study, Gut, 54, 122, 10.1136/gut.2003.036566

2001, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486

Struben, 2000, Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds, Am J Med, 108, 9, 10.1016/S0002-9343(99)00315-0

Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604

Harrison, 2003, The natural history of nonalcoholic fatty liver disease: a clinical histopathological study, Am J Gastroenterol, 98, 2042, 10.1111/j.1572-0241.2003.07659.x

Ratziu, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324

Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114

Caldwell, 2002, Subacute liver failure in obese women, Am J Gastroenterol, 97, 2058, 10.1111/j.1572-0241.2002.05922.x

Hui, 2003, Longterm outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320

Fassio, 2004, Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies, Hepatology, 40, 820

Adams, 2005, The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies, J Hepatol, 42, 132, 10.1016/j.jhep.2004.09.012

Brun, 2000, Diabetes duration and cause-specific mortality in the Verona Diabetes Study, Diabetes Care, 23, 1119, 10.2337/diacare.23.8.1119

Capron, 1982, Fasting in obesity: another cause of liver injury with alcoholic hyaline?, Dig Dis Sci, 27, 265, 10.1007/BF01296926

Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168

Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1002/hep.1840360609

Shimada, 2002, Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis, J Hepatol, 37, 154, 10.1016/S0168-8278(02)00099-5

Davila, 2005, Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study, Gut, 54, 533, 10.1136/gut.2004.052167

Powell, 2005, Steatosis: co-factor in other liver diseases, Hepatology, 42, 5, 10.1002/hep.20750

Caldwell, 2004, Obesity and hepatocellular carcinoma, Gastroenterology, 127, S97, 10.1053/j.gastro.2004.09.021

Adams, 2005, Recent concepts in non-alcoholic fatty liver disease, Diabetic Medicine, 21, 1129, 10.1111/j.1464-5491.2005.01748.x

Charlton, 2001, Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease, Liver Transpl, 7, 608, 10.1053/jlts.2001.25453

Bhattacharjya, 2004, Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic outcomes, Dig Surg, 21, 152, 10.1159/000078741

Ayata, 2002, Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation, Hum Pathol, 33, 1098, 10.1053/hupa.2002.129419

Mofrad, 2003, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229

Hickman, 2004, Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life, Gut, 53, 413, 10.1136/gut.2003.027581

Ioannou, 2005, Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease, Gastroenterology, 128, 627, 10.1053/j.gastro.2004.12.004

Wanless, 2004, The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis, Semin Liver Dis, 24, 99, 10.1055/s-2004-823104

Hui, 2004, Beyond insulin resistance in NASH: TNF-alpha or adiponectin?, Hepatology, 40, 19, 10.1002/hep.20280

Bugianesi, 2005, Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to disease severity, J Clin Endocrinol Metab, 90, 3498, 10.1210/jc.2004-2240

Kaser, 2005, Adiponectin and its receptors in non-alcoholic steatohepatitis, Gut, 54, 117, 10.1136/gut.2003.037010

Diehl, 2005, Cytokines and the pathogenesis of non-alcoholic steatohepatitis, Gut, 54, 303, 10.1136/gut.2003.024935

Park, 2004, Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men, J Gastroenterol Hepatol, 19, 694, 10.1111/j.1440-1746.2004.03362.x

Hui, 2004, High sensitivity CRP protein values do not reliably predict the severity of histological change in NAFLD (letter), Hepatology, 39, 1458, 10.1002/hep.20223

Bugianesi, 2004, Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in non-alcoholic fatty liver, Hepatology, 39, 179, 10.1002/hep.20023

Younossi, 1999, Hepatic iron and nonalcoholic fatty liver disease, Hepatology, 30, 847, 10.1002/hep.510300407

Chitturi, 2002, HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity, Hepatology, 36, 142, 10.1053/jhep.2002.33892

Joseph, 1991, Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease, Clin Radiol, 43, 26, 10.1016/S0009-9260(05)80350-2

Saadeh, 2002, The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, 123, 745, 10.1053/gast.2002.35354

Fishbein, 2005, J Clin G, astroenterol, 39, 619

Mottin, 2004, The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients, Obes Surg, 14, 635, 10.1381/096089204323093408

Mitchell, 1992, Focal manifestations of diffuse liver disease at MR imaging, Radiology, 185, 1, 10.1148/radiology.185.1.1523289

Debacre, 1998, Transient focal fatty liver infiltration mimicking liver metastasis, J Belge Radiol, 81, 174

Ataseven, 2005, The value of ultrasonography and computerized tomograph in estimating the histopathological severity of nonalcoholic steatohepatitis, Acta Gastroenterol Belg, 68, 221

Szczepaniak, 2005, Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population, Am J Physiol Endocrinol Metab, 288, E462, 10.1152/ajpendo.00064.2004

Friedman, 2004, Controversies in liver biopsy: who, where, when, how, why?, Curr Gastroenterol Rep, 6, 30, 10.1007/s11894-004-0023-4

Joy, 2003, Diagnosis of fatty liver disease: is biopsy necessary?, Eur J Gastroenterol Hepatol, 15, 539

Suzuki, 2005, Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease, Liver Int, 25, 779, 10.1111/j.1478-3231.2005.01064.x

Sakugawa, 2005, Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease, World J Gastroenterol, 11, 255, 10.3748/wjg.v11.i2.255

Rosenberg, 2004, Serum markers detect the presence of fibrosis: a cohort study, Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052

Bookman, 2005, Does serum hyaluronic acid help distinguish fibrosing steatohepatits (severe NASH) from benign forms of non-alcoholic fatty liver disease (NAFLD)? Value of the HAGL score [Abstract], Hepatology, 42, 623A

Lowell, 2005, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343

Samuel, 2004, Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease, J Biol Chem, 279, 32345, 10.1074/jbc.M313478200

Browning, 2004, Molecular mediators of hepatic steatosis and liver injury, J Clin Invest, 114, 147, 10.1172/JCI200422422

Sanyal, 2001, Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities, Gastroenterology, 120, 1183, 10.1053/gast.2001.23256

Friedman, 2002, Fat in all the wrong places, Nature, 415, 268, 10.1038/415268a

Kraegen, 1991, Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats, Diabetes, 40, 1397, 10.2337/diab.40.11.1397

Kim, 2001, Tissuespecific overexpression of lipoprotein lipase causes tissue-specific insulin resistance, Proc Natl Acad Sci U S A, 98, 7522, 10.1073/pnas.121164498

Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N Engl J Med, 350, 664, 10.1056/NEJMoa031314

Caldwell, 1999, Mitochondrial abnormalities in non-alcoholic steatohepatitis, J Hepatol, 31, 430, 10.1016/S0168-8278(99)80033-6

Farrell, 2005, Signalling links in the liver: Knitting SOCS with fat and inflammation, J Hepatol, 43, 193, 10.1016/j.jhep.2005.04.004

Weltman, 1998, Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis, Hepatology, 27, 128, 10.1002/hep.510270121

Chalasani, 2003, Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis, Hepatology, 37, 544, 10.1053/jhep.2003.50095

Leclercq, 2000, Cyp2e1 and Cyp4a as microsomal catalysts of lipid peroxides in murine non-alcoholic steatohepatitis, J Clin Invest, 105, 1067, 10.1172/JCI8814

Robertson, 2001, Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P450 enzymes and oxidative stress, Am J Physiol Gastrointest Liver Physiol, 281, G1135, 10.1152/ajpgi.2001.281.5.G1135

Schattenberg, 2005, Hepatic CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling, J Biol Chem, 280, 9887, 10.1074/jbc.M410310200

Cai, 2005, Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB, Nat Med, 11, 183, 10.1038/nm1166

Charlton, 2002, Apolipoprotein synthesis in nonalcoholic steatohepatitis, Hepatology, 35, 898, 10.1053/jhep.2002.32527

Masaki, 2004, Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice, Hepatology, 40, 19, 10.1002/hep.20282

Xu, 2003, The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice, J Clin Invest, 112, 91, 10.1172/JCI200317797

Larter, 2006, Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat?, J Hepatol, 44, 253, 10.1016/j.jhep.2005.11.030

Carmiel-Haggai, 2005, A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats, FASEB J, 19, 136, 10.1096/fj.04-2291fje

Donnelly, 2005, Sources of fatty acids stored in liver and secreted with lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, 115, 1343, 10.1172/JCI23621

Day, 1998, Steatohepatitis: a tale of two“hits”?, Gastroenterology, 114, 842, 10.1016/S0016-5085(98)70599-2

Deng, 2005, Steatohepatitis induced by intragastric overfeeding in mice, Hepatology, 42, 905, 10.1002/hep.20877

Memon, 2001, TNF-α is not the cause of fatty liver disease in obese mice, Nat Med, 7, 2, 10.1038/83316

George, 2003, Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis, J Hepatol, 39, 756, 10.1016/S0168-8278(03)00376-3

Feldstein, 2005, Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 3, 384, 10.1016/S1542-3565(04)00616-0

Ip, 2004, Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice, Hepatology, 39, 1286, 10.1002/hep.20170

McCuskey, 2004, Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice, Hepatology, 40, 386, 10.1002/hep.20302

Paradis, 2001, High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression of fibrosis in nonalcoholic steatohepatitis, Hepatology, 34, 738, 10.1053/jhep.2001.28055

Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801

2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512

Palmer, 1990, Effect of weight reduction on hepatic abnormalities in overweight patients, Gastroenterology, 99, 1408, 10.1016/0016-5085(90)91169-7

Ueno, 1997, Therapeutic effects of restricted diet and exercise in obese patients with fatty liver, J Hepatol, 27, 103, 10.1016/S0168-8278(97)80287-5

Huang, 2005, One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study, Am J Gastroenterol, 100, 1072, 10.1111/j.1572-0241.2005.41334.x

Dixon, 2004, Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss, Hepatology, 39, 1647, 10.1002/hep.20251

Laurin, 2004, Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study, Hepatology, 23, 1464, 10.1002/hep.510230624

Saibara, 1999, Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis, Lancet, 353, 1802, 10.1016/S0140-6736(05)75907-9

Neuschwander-Tetri, 2003, Improved non-alcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone, Hepatology, 38, 1008, 10.1002/hep.1840380427

Pomrat, 2004, A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis, Hepatology, 39, 188, 10.1002/hep.20012

Bugianesi, 2005, A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease, Am J Gastroenterol, 100, 1082, 10.1111/j.1572-0241.2005.41583.x

Lindor, 2004, Ursodeoxycholic acid for treatment of non-alcoholic steatohepatitis: results of a randomized trial, Hepatology, 39, 770, 10.1002/hep.20092

Lavine, 2000, Vitamin E treatment of non-alcoholic steatohepatitis in children: a pilot study, J Pediatr, 136, 734, 10.1016/S0022-3476(00)05040-X

Sanyal, 2004, A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis, Clin Gastroenterol Hepatol, 2, 1107, 10.1016/S1542-3565(04)00457-4

Hasegawa, 2001, Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study, Aliment Pharmacol Ther, 15, 1667, 10.1046/j.1365-2036.2001.01083.x

Harrison, 2003, Vitamin E and vitamin C treatment improves fibrosis in patients with non-alcoholic steatohepatitis, Am J Gastroenterol, 98, 2485, 10.1111/j.1572-0241.2003.08699.x

Miglio, 2000, Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis, Arzneimittelforschung, 50, 722

Abdelmalek, 2001, Betaine, a promising new agent for patients with non-alcoholic steatohepatitis: results of a pilot study, Am J Gastroenterol, 96, 2711, 10.1111/j.1572-0241.2001.04129.x

Adams, 2004, A pilot trial of pentoxifylline in nonalcoholic steatohepatitis, Am J Gastroenterol, 99, 2365, 10.1111/j.1572-0241.2004.40064.x